Eukaryotic replication origins are defined by the ORC-dependent loading of the Mcm2-7 helicase complex onto chromatin in G1. Paradoxically, there is a vast excess of Mcm2-7 relative to ORC assembled onto chromatin in G1. These excess Mcm2-7 complexes exhibit little co-localization with ORC or replication foci and can function as dormant origins. We dissected the mechanisms regulating the assembly and distribution of the Mcm2-7 complex in the Drosophila genome. We found that in the absence of cyclin E/Cdk2 activity, there was a 10-fold decrease in chromatin-associated Mcm2-7 relative to the levels found at the G1/S transition. The minimal amounts of Mcm2-7 loaded in the absence of cyclin E/Cdk2 activity were strictly localized to ORC binding sites. In contrast, cyclin E/Cdk2 activity was required for maximal loading of Mcm2-7 and a dramatic genome-wide reorganization of the distribution of Mcm2-7 that is shaped by active transcription. Thus, increasing cyclin E/Cdk2 activity over the course of G1 is not only critical for Mcm2-7 loading, but also for the distribution of the Mcm2-7 helicase prior to S-phase entry.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331006PMC
http://dx.doi.org/10.15252/embj.201488307DOI Listing

Publication Analysis

Top Keywords

cyclin e/cdk2
16
e/cdk2 activity
16
mcm2-7 helicase
12
distribution mcm2-7
12
mcm2-7
11
helicase complex
8
loading mcm2-7
8
excess mcm2-7
8
mcm2-7 relative
8
absence cyclin
8

Similar Publications

Cyclin dependent kinase 2 (CDK2) is responsible for enforcing progression through the G1-S phase transition. Mutations and alterations in the CDK2 signaling pathway are associated with various cancers, most commonly breast, ovarian, prostate, leukemia, and lymphoma. CDK2 inhibitors have shown promising preclinical and early clinical results, and this class of agents may be most effective against cancers with cyclin E overactivity.

View Article and Find Full Text PDF

Coordinated expression of replication-dependent (RD) histones genes occurs within the Histone Locus Body (HLB) during S phase, but the molecular steps in transcription that are cell cycle regulated are unknown. We report that RNA Pol II promotes HLB formation and is enriched in the HLB outside of S phase, including G1-arrested cells that do not transcribe RD histone genes. In contrast, the transcription elongation factor Spt6 is enriched in HLBs only during S phase.

View Article and Find Full Text PDF

Gingival overgrowth caused by cyclosporine A is due to increased fibroblast proliferation in gingival tissues. Cell cycle system balances proliferation and anti-proliferation of gingival fibroblasts and plays a role in the maintenance of its population in gingival tissues. When cells detect and respond to abnormalities (e.

View Article and Find Full Text PDF

Antiā€‘proliferative effects of in a model for triple negative breast cancer.

Oncol Lett

February 2025

American Foundation for Chinese Medicine, New York, NY 10001, USA.

Triple negative breast cancer (TNBC) is characterized by the absence of hormones and growth factor receptors. It is typically responsive to anthracycline/taxol-based conventional chemotherapy. However, major therapeutic limitations include systemic toxicity and acquired resistance to chemotherapeutics.

View Article and Find Full Text PDF
Article Synopsis
  • Salisb. is a traditional herb used to treat various diseases, including gastric cancer, but its specific effects on gastric cancer cells require further investigation.
  • This study explored how a standardized extract of Salisb. rhizome induces cell death in gastric cancer AGS cells, primarily through apoptosis and cell cycle disruption.
  • The extract's active compounds, curdione and germacrone, were shown to affect mitochondrial function and cell cycle regulatory proteins, highlighting their potential as anti-cancer agents.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!